A clinical practice guideline from the American College of Physicians. Ann Intern Med 2005 Apr 5; 142:525-31. Li Z et al. Meta-analysis: Pharmacologic treatment of obesity. Ann Intern Med 2005 Apr ...

The guidelines’ lead author ... that evidence scrutinizing the long-term relationship between obesity treatment and eating disorders was thin — calling it “a gap in the literature.” ...

Updated European guidelines for metabolic dysfunction–associated steatotic liver disease stressed a higher risk in people ...

Obesity—the bad word everyone throws around, but few want to truly understand. The American Academy of Pediatricians thought ...

and there are no guidelines for surgery. The best treatment will depend on the individual, but the main options will be dietary measures and increased activity levels. Childhood obesity is ...

Just 800 of the 13,500 patients eligible to start receiving Wegovy, which can help obese people lose 15% of their body weight ...

John M. Burke, MD, examines how new obesity treatments, such as GLP-1 agonists, might influence future cancer rates.

As a pediatric obesity medicine specialist, I have witnessed first-hand the benefits of GLP-1 receptor agonists in the ...

Discover the growing demand for specialty training in obesity treatment as new options emerge. Learn about the current state and benefits of certification ...

She sees many people assuming that the GLP-1 agonists and related types of drugs will be the right treatment for everyone coping with obesity, or that GLP-1 agonists will be the wrong treatment ...

Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related diseases, new research has concluded.

A new study published in the journal of Diabetes Care found that pediatric obesity with metabolic dysfunction-associated ...